𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma

✍ Scribed by Chris P Lohmann; Gisela Kroher; Thomas Bogenrieder; Detlev Spiegel; Jürgen Preuner

Book ID
117312394
Publisher
The Lancet
Year
1999
Tongue
English
Weight
61 KB
Volume
353
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of metastatic malignant melano
Treatment of metastatic malignant melanoma with recombinant interferon alfa-2b
✍ T. Dorval; T. Palangie; M. Jouve; E. Garcia-Giralt; E. Falcoff; D. Schwab; M. Le 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 151 KB

Twenty-six patients with histologically proven metastatic malignant melanoma were included in a phase II trial of interferon alfa-2b (Intron A; Schering-Plough). Patients were given 10 X 10(6) IU/m2 of interferon alfa-2b subcutaneously three times a week until major intolerance or progression of dis